Medtronic's agnostic approach to global challenges, including tariffs and AI, ensures success and innovation in healthcare ...

The "U.S. Deep Brain Stimulation In Parkinson's Disease Market Size, Share & Trends Analysis Report By Product ...

A series of important developments in the healthcare sector includes Medtronic adapting to tariff threats, Hims & Hers facing ...

Medtronic said Monday the U.S. Food and Drug Administration has approved an adaptive brain-stimulation device as a treatment ...

The Financial Times recently reported that Johnson & Johnson (J&J) is considering the sale of Cerenovus, its neurovascular ...

The company, whose products range from insulin pumps to surgical robots, has been closely monitoring Trump's tariff plans due to its presence in Mexico.

Medical device maker Medtronic is looking at options to modify its global manufacturing footprint as part of efforts to ...

After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...

Medtronic plc, a global leader in healthcare technology, announced that Medtronic Malaysia and Malaysian Society of Colorectal Surgeons (MSCRS) have signed a Memorandum of Understanding (MoU) to ...

Medtronic USA Inc.'s argument that its implantable heart monitors are “medicines” exempt from sales tax seemed to divide two justices on a California appeals court panel at oral arguments Monday.

Recent developments in the health sector include Pfizer appointing Patrizia Cavazzoni as Chief Medical Officer and Amgen ...

There is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...